OTCMKTS:PHGUF

Pharming Group (PHGUF) Stock Price, News & Analysis

Pharming Group logo
$1.26 0.00 (0.00%)
As of 11/13/2026

About Pharming Group Stock (OTCMKTS:PHGUF)

Advanced

Key Stats

Today's Range
$1.26
▼
$1.26
50-Day Range
$0.93
▼
$1.26
52-Week Range
$0.93
▼
$2.17
Volume
N/A
Average Volume
54 shs
Market Capitalization
$845.55 million
P/E Ratio
39.39
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Pharming Group is a biotechnology company based in Leiden, the Netherlands, focused on developing and commercializing medicines for rare diseases. Its portfolio includes treatments for hereditary angioedema and activated phosphoinositide 3-kinase delta syndrome (APDS).

The company’s products include Ruconest (conestat alfa), a recombinant human C1 esterase inhibitor used to treat acute hereditary angioedema attacks, and Joenja (leniolisib), an oral treatment for APDS. Pharming developed Ruconest using a production process involving genetically modified rabbits.

Founded in 1988, Pharming serves patients in markets including the United States and Europe, with additional access supported through commercial partners. Its work also includes research and development of medicines for other rare diseases.

AI Generated. May Contain Errors.

Receive PHGUF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pharming Group and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

PHGUF Stock News Headlines

A $247 tool for $7
Bill Poulos is offering his $247 Instant Scanner for $7 in the Black Friday sale. It's one payment for a full year, with no re-bills and nothing to install. The catch? He isn't trying to profit on the scanner itself. Poulos is betting that once you see it deliver the night's list, you'll want more of his work for years.tc pixel
Pharming Group: Viable Contrarian Buy If Ruconest Stabilizes
See More Headlines

PHGUF Stock Analysis - Frequently Asked Questions

Pharming Group's stock was trading at $1.65 at the beginning of 2026. Since then, PHGUF shares have decreased by 23.6% and is now trading at $1.26.

Pharming Group NV (OTCMKTS:PHGUF) announced its earnings results on Tuesday, October, 27th. The biotechnology company reported $0.03 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.02 by $0.01. The biotechnology company earned $117.60 million during the quarter, compared to analysts' expectations of $117.60 million. Pharming Group had a net margin of 6.23% and a trailing twelve-month return on equity of 8.85%.

Shares of PHGUF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Pharming Group investors own include Pharming Group (PHAR), Lakefront Biotherapeutics American Depositary Shares (LKFT), ArcelorMittal (MT), Bausch Health Cos (BHC), Aegon (AEG), Aurora Cannabis (ACB) and Ayala Pharmaceuticals (ADXS).

Company Calendar

Last Earnings
10/27/2026
Today
11/16/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Biotechnology
Sub-Industry
Biotechnology
Current Symbol
OTCMKTS:PHGUF
Previous Symbol
OTC:PHGUF
CIK
N/A
Employees
407
Year Founded
1988

Profitability

EPS (Trailing Twelve Months)
$0.03
Trailing P/E Ratio
39.39
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$2.85 million
Net Margins
6.23%
Pretax Margin
4.31%
Return on Equity
8.85%
Return on Assets
4.96%

Debt

Debt-to-Equity Ratio
0.39
Current Ratio
3.01
Quick Ratio
2.31

Sales & Book Value

Annual Sales
$376.13 million
Price / Sales
2.25
Cash Flow
$0.02 per share
Price / Cash Flow
60.11
Book Value
$0.41 per share
Price / Book
3.07

Miscellaneous

Outstanding Shares
671,070,000
Free Float
N/A
Market Cap
$845.55 million
Optionable
Not Optionable
Beta
0.45

Social Links

10 Best Stocks to Own in Fall 2026 Cover

AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.

Get This Free Report

This page (OTCMKTS:PHGUF) was last updated on 11/13/2026 by MarketBeat.com Staff.
From Our Partners